Palomar (NASDAQ:PLMR) CEO Mac Armstrong Sells 3,500 Shares

Palomar Holdings, Inc. (NASDAQ:PLMR) CEO Mac Armstrong sold 3,500 shares of the stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $112.96, for a total transaction of $395,360.00. Following the completion of the transaction, the chief executive officer owned 329,388 shares in the company, valued at $37,207,668.48. This trade represents a 1.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mac Armstrong also recently made the following trade(s):

• On Thursday, May 21st, Mac Armstrong sold 3,500 shares of Palomar stock. The stock was sold at an average price of $114.39, for a total transaction of $400,365.00.
• On Tuesday, April 21st, Mac Armstrong sold 3,500 shares of Palomar stock. The shares were sold at an average price of $130.77, for a total transaction of $457,695.00.
• On Wednesday, April 15th, Mac Armstrong sold 3,197 shares of Palomar stock. The shares were sold at an average price of $129.46, for a total transaction of $413,883.62.

Palomar Stock Up 2.4%

PLMR opened at $118.91 on Thursday. The firm’s 50 day simple moving average is $115.79 and its two-hundred day simple moving average is $122.36. The company has a market capitalization of $3.15 billion, a PE ratio of 16.56 and a beta of 0.44. Palomar Holdings, Inc. has a 1-year low of $100.81 and a 1-year high of $161.35. The company has a current ratio of 0.49, a quick ratio of 0.49 and a debt-to-equity ratio of 0.31.

Palomar (NASDAQ:PLMR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $2.31 EPS for the quarter, topping the consensus estimate of $2.17 by $0.14. Palomar had a return on equity of 22.62% and a net margin of 20.11%.The firm had revenue of $278.94 million during the quarter, compared to analyst estimates of $557.79 million. During the same period in the prior year, the business posted $1.87 EPS. Palomar’s revenue was up 59.7% on a year-over-year basis. As a group, equities analysts forecast that Palomar Holdings, Inc. will post 9.14 EPS for the current year.

Key Headlines Impacting Palomar

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Zacks Research raised its FY2026 earnings estimate for Palomar to $9.87 per share from $8.99, suggesting stronger near-term profit potential. Palomar Holdings analyst update
• Positive Sentiment: Zacks also increased estimates for Q2 2026, Q2 2027, and Q4 2027, which may reinforce expectations that Palomar can sustain earnings growth over time. Palomar Holdings analyst update
• Positive Sentiment: A Zacks article highlighted Palomar as one of the property & casualty insurers positioned to weather the 2026 hurricane season, citing resilient pricing and digitalization trends. Article about P&C insurers poised to weather hurricane season
• Neutral Sentiment: Zacks Research maintained a Hold rating, signaling that analysts see limited short-term upside despite the improved earnings outlook. Palomar Holdings analyst rating
• Neutral Sentiment: Palomar CEO Mac Armstrong sold 3,500 shares under a pre-arranged 10b5-1 plan, a routine insider transaction that may not reflect a change in business fundamentals. SEC insider filing
• Negative Sentiment: Zacks trimmed some future estimates, including Q3 2026, Q1 2027, Q3 2027, and FY2028, which could temper enthusiasm around the pace of Palomar’s growth. Palomar Holdings analyst update

Institutional Trading of Palomar

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Royal Bank of Canada boosted its stake in Palomar by 49.1% in the 1st quarter. Royal Bank of Canada now owns 2,956 shares of the company’s stock worth $406,000 after purchasing an additional 974 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Palomar by 5.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,427 shares of the company’s stock valued at $2,115,000 after buying an additional 791 shares during the last quarter. NewEdge Advisors LLC purchased a new position in shares of Palomar in the first quarter worth $66,000. United Services Automobile Association purchased a new position in shares of Palomar in the first quarter worth $223,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Palomar by 11.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 72,661 shares of the company’s stock worth $9,960,000 after acquiring an additional 7,754 shares during the last quarter. Institutional investors own 90.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on PLMR. Zacks Research cut Palomar from a “strong-buy” rating to a “hold” rating in a research report on Friday, May 15th. Weiss Ratings upgraded shares of Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, June 18th. JPMorgan Chase & Co. lowered their price target on shares of Palomar from $160.00 to $150.00 and set an “overweight” rating on the stock in a report on Tuesday, May 26th. Wall Street Zen lowered shares of Palomar from a “buy” rating to a “hold” rating in a research report on Sunday, March 1st. Finally, Keefe, Bruyette & Woods reduced their price objective on shares of Palomar from $186.00 to $159.00 and set an “outperform” rating for the company in a research note on Wednesday, May 13th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $147.75.

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.